profit from every €100 of sales.
€0€100
Exosens
€53.80+0.37% today
+12.2% since Dec 19, 25
1-year low €46.451-year high €72.90
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay €88.80 for every €1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Exosens sold, what it kept, and what it did with the cash.
Sales went from €201 million in 2022 to €383 million in 2025, with €30.7 million of profit last year.
SalesProfit
Exosens handed back 13% of the cash it generated last year.
Buybacks €9M€5M
Free cash flow 2025€107M
Bought back its own shares€9M
Paid as dividends€5M
Cash vs. debt€69M vs. €17M
Exosens vs. similar companies
Exosens grows the fastest of these 5 and is priced in the middle for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Exosens | 88.8× · Very expensive | ||
 Contemporary Amperex Technology | 20.6× · Fair price | ||
 ABB | 32.0× · Expensive | ||
 Vertiv | 56.1× · Expensive | ||
 Delta Electronics (Thailand) Public | 97.0× · Very expensive |
AI analysis
An AI analyst reads Exosens's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 201 | 292 | 468 | 383 | |
| 114 | 212 | 278 | 222 | |
| 33 | 55 | 102 | 81 | |
| 51 | 75 | 142 | 120 | |
| 11 | 18 | 43 | 31 | |
| 0.37 | 0.24 | 0.84 | 0.60 | |
| 56.8% | 72.5% | 59.3% | 58.0% | |
| 16.4% | 18.7% | 21.8% | 21.0% | |
| 5.6% | 6.3% | 9.1% | 8.0% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 529 | 656 | 817 | 879 |
| Cash | 29 | 15 | 117 | 69 |
| Total debt | 249 | 312 | 11 | 17 |
| Total liabilities | 346 | 452 | 404 | 433 |
| 183 | 204 | 413 | 446 | |
| 30 | 30 | 51 | 51 | |
| 5.6% | 6.9% | 18.1% | 13.1% | |
| 6.1% | 9.0% | 10.3% | 6.9% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 47 | 51 | 99 | 107 | |
| 22 | 31 | – | – | |
| 26 | 51 | 99 | 107 | |
| Dividends paid | – | – | – | 5 |
| – | 0 | 0 | 9 | |
| – | – | – | – |
Valuation
- 88.8×
- –
- 4.99
- 7.1×
- 7.1×
- 25.4×
- 22.3×
- 3.9%
- 1.1%
- 0.2%
Profitability
- 58.0%
- 21.0%
- 8.0%
- –
- 13.1%
- 10.9%
- –
- –
- –
- –
Growth
- +24.1%
- +17.8%
- –
- –
- +18.8%
Financial health
- -0.4×
- 0.04
- –
- –
- 2.46
- –
- –
How it ranks in Industrials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 22%of 980
Top 11%of 984
Bottom 5%of 864
Top 10%of 984
Top 47%of 986
0.2%of the share price, paid each year
On $1,000 invested$2a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
16.6% of its profit
Room to growStretchedMore than it earns: 4.7%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
62Pass
Benjamin Graham
46No pass
Philip Fisher
52No pass
Peter Lynch
51No pass
Joel Greenblatt
13No pass
Charlie Munger
47No pass
Terry Smith
45No pass
Questions about Exosens
Is Exosens a good stock to buy?
A solid business, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Exosens AI analysis
What does Exosens do?
Exosens, together with its subsidiaries, develops, manufactures, and sells electro-optical technologies in France, Europe, North America, Asia, and internationally. It operates in two segments, Amplification and Detection and Imaging. It is in Electrical Equipment & Parts, based in Mérignac, France, with 1,499 employees.
Does Exosens pay a dividend?
Yes. At today's price the dividend is 0.2% a year, about 17% of its yearly profit. In 2025 it paid out €5.10 million in dividends.
Is Exosens stock halal?
Yes. Exosens passes our halal screen: its business is permitted and its debt is 0.6% of its market value, under the 30% limit. How we check
Who are Exosens's competitors?
The largest listed companies in the same industry are Contemporary Amperex Technology, ABB, Vertiv and Delta Electronics (Thailand) Public. The peers table on this page compares their profit, growth and price with Exosens's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.